AstraZeneca's earnings top estimates but shares fall on core operating profit drop

Go back to AstraZeneca's earnings top estimates but shares fall on core operating profit drop

AstraZeneca Full year and Q4 2023 Financial Results

February 8, 2024 2:04 AM EST

Strong growth and pipeline momentum with three new medicines approved since the third quarter

CAMBRIDGE, United Kingdom--(BUSINESS WIRE)-- AstraZeneca:

Revenue and EPS summary

 

 

FY 2023

Q4 2023

 

 

 

%... More